Search

PharmExec.com has named phage therapy as one of the top 10 drug discovery trends to watch in 2019!

Want to win one of 50 free copies of The Perfect Predator, the true story of how a global village saved the life of Tom Patterson with IV phage therapy? Sign up for the book giveaway on Goodreads.com by Jan 23. Note: you need to view it fro

Mahmuda Akter I have been working at the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) and earned my M.S. degree from the University of Dhaka in Bangladesh. I was awarded joint funding from icddr,b and SIDA to i

We are looking to recruit a Postdoc Bioinformatics / (Pro-)phage genomics. The successful candidate will work in an ERC funded project (ERC starting grant “Pro_Phage”) and will be part a Helmholtz research group located at the Institute of

Dr. Evelien Adriaenssens Dr. Evelien Adriaenssens is looking for a phage enthusiast to join her group at the Quadram Institute Bioscience in Norwich (UK). The work will be focused on developing a protocol for isolation of novel gut bacterio

Dr. José R. Penadés José R. Penadés of the University of Glasgow is hiring a postdoctoral researcher to investigate whether phage-mediated lateral transduction, a recently-described phenomenon, is widespread in nature. University of Glasgow

Dr. Edze Westra Dr. Edze Westra of the University of Exeter has a postdoctoral position that will focus on virus communication systems. The project will involve collaboration with Rotem Sorek, Angus Buckling, Kai Papenfort and Sylvain Gando

Silviane Miruka I am a student seeking a PhD opportunity in a phage lab. I recently did a project for my master's thesis titled "Molecular Detection of Pathogenic Staphylococcus aureus Using Phage Based Genetic Markers." Please email me at

People are starting to ask questions about phage therapy. We need your help to put together an FAQ. Do they qualify? How can they get it, and where do they get it? ## First things first: we're building a crowdsourced phage FAQ page We’d lik

IPATH has just received FDA approval to start its first clinical trial! This will be the first US trial involving intravenous (IV) phage treatment, and will be a collaboration with Ampliphi Biosciences.

Adaptive Phage Therapeutics has partnered with Yale University to manufacture and supply phages for use in Yale's upcoming clinical trials.

Johnson & Johnson has invested $20 million (with another ~$800 million to follow if things go well) into Locus Biosciences, a biotech company equipping phages with CRISPR-Cas3 to obliterate bacterial DNA upon phage infection.

A phase II clinical trial for a phage lysin has been deemed successful! An anti-Staphylococcus aureus phage lysin, called exebacase, was just found to be both safe and effective at treating MRSA in patients. Exebacase is being developed by

The phage therapy biotech company Ampliphi Biosciences is merging with C3J Therapeutics, a synthetic phage/antimicrobial engineering company.

Due to the partial U.S. government shutdown, ASM is extending the deadline for ASM Microbe abstract submissions to January 25, 2019.

Thanks to support from Roche Molecular Diagnostics and Intralytix, ASM Division M will provide 4 travel awards to students presenting phage work at ASM Microbe 2019! To apply, use "phage" as a keyword in your submitted abstract. Before you

Gunaraj Dhungana Kathmandu, Nepal My name is Gunaraj Dhungana, I'm a Ph.D scholar from the central Department of Biotechnology, Tribhuvan University, Nepal. We have sequenced the whole genome of four lytic phages against carbapenem-resistan

Piotr Tynecki I'm working on a deep learning-based analysis of phage genomes considering their lytic/lysogenic potential. I'm looking for complete phage genome sequences in FASTA format with lytic/lysogenic labels that have been confirmed b

Muhammad Akmal I am Muhammad Akmal, working as a Lecturer at the Department of Fisheries and Aquaculture, University of Veterinary and Animal Sciences, Lahore, Pakistan since July 2014, where I also received my Bachelors and Masters degrees

Sian Owen Cambridge, MA I'm a postdoc at Harvard Medical School researching a novel phage-immunity system in Salmonella enterica sv. Typhimurium. I’m looking for characterised (and ideally genome sequenced/published) phages infecting S. Typ